Amexdrug Corporation (AXRX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Jul 10, 2026
Amexdrug Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '13 Jun 30, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 |
Revenue Revenue Growth | 9.17 | 9.15 | 12.41 | 11.49 | 9.77 | 5.69 |
Revenue Growth | -12.19% | -26.26% | 8.00% | 17.61% | 71.55% | -7.27% |
Gross Profit Gross Profit Growth | 1.27 | 1.01 | 1 | 0.96 | 0.72 | 0.45 |
Operating Income Operating Income Growth | 0.33 | 0.2 | 0.22 | 0.29 | 0.06 | 0.03 |
Net Income Net Income Growth | 0.17 | 0.08 | 0.1 | 0.19 | 0.02 | 0.01 |
Earnings Per Share EPS Growth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Growth | 1359.70% | -18.52% | -46.77% | 933.33% | 50.00% | 7.46% |
Revenue by Segment
Fiscal Year | TTM | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '13 Jun 30, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 |
Distributions Distributions Growth | 6.71 | 7.25 | 10.97 | 10.39 | 9.36 | 5.46 |
Health and Beauty Products Health and Beauty Products Growth | 2.46 | 1.89 | 1.43 | 1.09 | 0.41 | 0.24 |
Total Total Growth | 9.17 | 9.15 | 12.41 | 11.49 | 9.77 | 5.69 |
Fiscal Year | Current | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '13 Jun 30, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 |
Cash & Investments Cash & Investments Growth | 0.17 | 0.42 | 0.59 | 0.45 | 0.13 | 0.1 |
Total Debt Total Debt Growth | 0.96 | 1.2 | 0.74 | 0.42 | 0.31 | 0.2 |
Net Cash (Debt) Net Cash Growth | -0.79 | -0.78 | -0.15 | 0.03 | -0.18 | -0.1 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 | -0.00 |
Fiscal Year | TTM | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '13 Jun 30, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 |
Operating Cash Flow Operating Cash Flow Growth | -0.07 | -0.16 | -0.14 | 0.23 | -0.06 | -0.19 |
Capital Expenditures CapEx Growth | -0.46 | -0.46 | -0.04 | -0 | -0.01 | -0 |
Free Cash Flow Free Cash Flow Growth | -0.54 | -0.62 | -0.18 | 0.22 | -0.07 | -0.2 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '13 Jun 30, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 |
Gross Margin | 13.80% | 11.00% | 8.03% | 8.38% | 7.39% | 7.98% |
Operating Margin | 3.61% | 2.14% | 1.78% | 2.53% | 0.57% | 0.58% |
Pretax Margin | 3.12% | 1.75% | 1.51% | 2.31% | 0.28% | 0.30% |
Profit Margin | 1.81% | 0.90% | 0.81% | 1.65% | 0.19% | 0.22% |
FCF Margin | -5.85% | -6.77% | -1.45% | 1.94% | -0.75% | -3.44% |
Fiscal Year | Current | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 |
PE Ratio | 0.20 | 103.08 | 168.06 | 89.47 | 1014.33 | 700.61 |
P/FCF Ratio | - | - | - | 75.94 | - | - |
PS Ratio | 0.00 | 0.92 | 1.36 | 1.47 | 1.91 | 1.52 |